Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices

por Rahalkar, Hasumati, Sheppard, Alan, Salek, Sam
Publicado 2021

Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study

por Rahalkar, Hasumati, Sheppard, Alan, Lopez-Morales, Carlos Augusto, Lobo, Luciano, Salek, Sam
Publicado 2021

Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities

por Rahalkar, Hasumati, Sheppard, Alan, Santos, Gustavo Mendes Lima, Dasgupta, Chitralekha, Perez-Tapia, Sonia Mayra, Lopez-Morales, Carlos A., Salek, Sam
Publicado 2021